lassa
fever
acut
viral
hemorrhag
ill
occur
west
africa
pose
seriou
public
health
threat
mani
countri
sogoba
et
al
shaffer
et
al
casefat
rate
overal
infect
sever
case
among
patient
hospit
mortal
rate
increas
sharpli
epidem
pregnant
women
asogun
et
al
etiolog
agent
lassa
fever
lassa
viru
lasv
belong
arenaviru
famili
arenaviru
member
divid
two
group
new
world
virus
tacarib
complex
old
world
virus
lcmlassa
complex
new
world
famili
mainli
contain
venezuelan
hemorrhag
fever
vhf
viru
junv
machupo
viru
macv
bolivian
hemorrhag
fever
bhf
old
world
virus
includ
exampl
lujo
viru
lujv
lymphocyt
choriomening
viru
lcmv
morogoro
viru
morv
lasv
arenavirus
geograph
genet
differ
lassa
viru
envelop
singlestrand
rna
viru
two
rna
segment
genom
encod
four
viral
protein
includ
zincbind
protein
z
rna
polymeras
l
nucleoprotein
np
surfac
glycoprotein
precursor
gp
spike
protein
gp
cleav
envelop
glycoprotein
cao
et
al
respons
receptor
bind
includ
heparin
sulfat
dcsign
etc
mediat
membran
fusion
interact
form
stabl
trimer
complex
lasv
viral
envelop
li
et
al
hasti
et
al
upon
receptor
bind
lasv
enter
target
cell
via
clathrin
dynaminindepend
endocytosi
subsequ
transport
late
endosom
compart
fusion
occur
low
ph
vela
et
al
rojek
et
al
recent
studi
also
found
bind
cell
receptor
lasv
enter
target
cell
unusu
micropinocytosi
pathway
membran
fusion
low
ph
condit
opplig
et
al
far
approv
vaccin
specif
treatment
modal
lasv
avail
given
first
peptidebas
antivir
drug
enfuvirtid
inhibit
human
immunodefici
viru
hiv
fusion
entri
target
cell
target
heptad
repeat
domain
viral
envelop
glycoprotein
qi
et
al
su
et
al
heptad
repeat
domain
lasv
may
also
serv
target
design
lasv
fusion
inhibitor
previous
demonstr
ntermin
heptad
repeat
domain
bind
ctermin
heptad
repeat
domain
form
stabl
sixhelix
bundl
mediat
viral
entri
therefor
peptid
deriv
specif
bind
homotrimer
interf
format
henc
block
viral
entri
zhu
et
al
xia
et
al
therefor
essenti
determin
core
structur
character
interact
site
domain
order
design
peptid
lasv
infect
solv
crystal
structur
postfus
form
lasv
domain
base
structur
design
sever
peptid
span
domain
test
antivir
activ
concurr
prepar
present
manuscript
anoth
group
report
postfus
structur
lasv
use
insect
baculoviru
express
system
shulman
et
al
allow
us
compar
structur
differ
core
form
domain
truncat
version
lasv
span
residu
lasv
construct
comparison
provid
comprehens
knowledg
better
understand
entri
mechan
lasv
design
peptidebas
lasv
fusion
inhibitor
cell
line
obtain
atcc
manassa
va
unit
state
cell
line
cell
bank
chines
academi
scienc
shanghai
china
two
cell
line
propag
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
peptid
synthes
solidphas
peptid
synthesi
syn
inc
shanghai
china
recombin
plasmid
encod
lasv
gpc
protein
synthes
syn
inc
gene
code
construct
lasv
residu
mutat
truncat
amplifi
pcr
clone
vector
artifici
introduc
presciss
proteas
cleavag
site
nterminu
stabl
express
fusion
protein
overexpress
escherichia
coli
cell
grown
lysogeni
broth
lb
media
supplement
kanamycin
induc
mm
iptg
h
express
cell
harvest
centrifug
g
min
lyse
high
pressur
homogen
twice
resuspens
buffer
contain
mm
ph
mm
nacl
inclus
bodi
harvest
centrifug
xg
min
resuspend
buffer
contain
mm
mm
nacl
ph
urea
mm
dtt
trimer
lasv
protein
refold
use
limit
dilut
method
briefli
denatur
protein
dilut
volum
ratio
renatur
buffer
mm
mm
nacl
ph
mm
arginin
mm
gsh
mm
gssg
slowli
mlmin
store
week
refold
protein
isol
niaffin
chromatographi
purifi
anion
exchang
chromatographi
hitrap
q
fast
flow
ml
ge
healthcar
well
gel
filtrat
chromatographi
superdex
gl
ge
healthcar
concentr
mgml
crystal
storag
use
crystal
obtain
day
use
hang
drop
vapor
diffus
method
mix
equal
volum
protein
solut
mgml
reservoir
solut
ammonium
acet
sodium
citrat
hcl
ph
wv
peg
vv
glycerol
crystal
flashfrozen
immers
paraffin
oil
follow
transfer
liquid
nitrogen
data
collect
dataset
collect
beamlin
shanghai
synchrotron
radiat
facil
wavelength
crystal
kept
k
xray
diffract
data
collect
data
index
scale
otwinowski
minor
phase
solv
molecular
replac
method
use
phenixphas
mccoy
refin
procedur
carri
phenixrefin
zwart
et
al
coot
emsley
cowtan
tabl
show
detail
statist
data
collect
refin
coordin
structur
factor
deposit
protein
data
bank
access
number
crystal
structur
fusion
core
lasv
protein
biolay
interferometri
bli
common
techniqu
detect
interact
substanc
work
principl
method
molecul
immobil
surfac
sensor
form
biolay
therebi
caus
interfer
light
wave
pass
sensor
detect
form
phase
displac
chang
number
molecul
surfac
sensor
detect
base
principl
mobil
phase
nonspecif
combin
sensor
sensor
type
select
experi
super
streptavidin
ssa
biosensor
test
perform
use
octet
biotinyl
protein
immobil
onto
ssa
carri
accord
follow
procedur
activ
biotin
reagent
prepar
dmso
concentr
mgml
peptid
mix
biotin
reagent
molar
ratio
peptid
biotin
reagent
reaction
incub
room
temperatur
h
free
biotin
remov
dialysi
biotinyl
protein
immobil
onto
ssa
concentr
load
time
concentr
mobil
phase
initi
test
concentr
gradient
test
associ
time
dissoci
time
secondari
structur
peptid
residu
residu
well
mixtur
determin
cd
spectroscopi
briefli
peptid
dilut
phosphatebuff
salin
pb
ph
incub
min
cd
spectra
acquir
jasco
spectropolarimet
model
jasco
inc
easton
md
unit
state
nm
room
temperatur
use
optic
path
length
cm
bandwidth
nm
baselin
determin
use
pb
content
calcul
cd
signal
divid
mean
residu
ellipt
nm
valu
expect
helic
format
degre
lassa
viru
pseudovirus
construct
describ
previous
li
et
al
wang
et
al
briefli
cell
seed
tissu
cultur
dish
cell
grown
dish
reach
confluenc
cell
cotransfect
plasmid
encod
gpc
protein
lasv
encod
envdefect
luciferaseexpress
capsid
protein
ratio
use
vigofect
vigor
biotechnolog
beij
china
supernat
replac
fresh
dmem
h
posttransfect
harvest
incub
addit
h
cell
debri
remov
centrifug
rpm
min
follow
filtrat
filter
lasv
pseudoviru
inhibit
assay
perform
manner
similar
envelop
viru
assay
lu
et
al
channappanavar
et
al
xia
et
al
briefli
cell
place
cellswel
plate
incub
overnight
lasv
pseudoviru
incub
serial
dilut
peptid
min
follow
addit
cell
cell
incub
without
pseudoviru
viru
control
cell
control
respect
h
postinfect
cultur
replac
fresh
medium
follow
addit
incub
h
cell
lyse
cell
lysat
transfer
costar
flatbottom
luminomet
plate
corn
costar
new
york
ny
unit
state
follow
addit
luciferas
substrat
promega
measur
luminesc
use
infinit
pro
tecan
austria
lassa
viru
gpc
proteinmedi
fusion
perform
previous
describ
cosset
et
al
briefli
plasmid
paavireslasvegfp
encod
lasv
gpc
protein
transfect
cell
use
transfect
reagent
vigofect
vigor
gfp
obvious
express
cell
cell
digest
mix
cell
ratio
mixtur
incub
cellswel
well
plate
h
peptid
serial
dilut
low
ph
dmem
ad
mixtur
cell
cell
min
exposur
low
ph
medium
trigger
fusion
cell
cell
cell
restor
neutral
medium
cultur
h
cell
fuse
unfus
cell
fix
pfa
count
invert
fluoresc
microscop
nikon
tokyo
japan
fuse
cell
show
much
larger
size
weaker
fluoresc
intens
unfus
cell
diffus
egfp
one
cell
cell
protein
contain
ntermin
fusion
peptid
fp
residu
ntermin
domain
residu
linker
tloop
domain
residu
ctermin
domain
residu
transmembran
domain
residu
intracellular
domain
residu
figur
multipl
sequenc
align
repres
arenavirus
like
lcmv
junv
macv
lasv
show
highli
conserv
tloop
domain
variabl
domain
figur
two
end
domain
conserv
middl
region
rel
uniqu
may
help
adapt
variabl
domain
lasv
reveal
interact
domain
lasv
stabl
cover
tloop
domain
residu
construct
crystallograph
studi
denatur
renatur
use
acquir
stabl
inclus
bodi
mimic
postfus
state
refold
process
wild
type
lasv
protein
mainli
form
precipit
high
polym
singl
mutat
introduc
trimer
lasv
protein
obtain
figur
howev
largescal
crystal
screen
protein
could
yield
highqual
crystal
continu
tri
differ
truncat
delet
final
found
delet
tloop
region
could
yield
protein
crystal
enough
qualiti
structur
determin
overal
structur
domain
show
canon
structur
figur
take
rodlik
shape
length
diamet
lasv
fusion
core
contain
parallel
trimer
coiledcoil
three
helic
gray
figur
around
three
helic
entwin
green
figur
antiparallel
manner
two
domain
tloop
form
helix
linker
hover
outsid
cyan
figur
accord
structur
shown
electrostat
potenti
surfac
figur
region
lasv
divid
two
part
linear
ntermin
region
helic
ctermin
region
linear
ntermin
region
bind
two
adjac
helic
hydrophob
interact
consist
fusion
core
structur
previous
determin
lu
et
al
obviou
charg
interact
take
place
helic
ctermin
region
trimer
core
discuss
later
anoth
group
deposit
postfus
structur
lasv
pdb
entri
code
use
baculoviru
express
system
instead
renatur
method
compar
structur
helic
region
structur
exhibit
signific
shift
toward
hydrophob
groov
two
adjac
helic
show
much
stronger
hydrophob
interact
figur
e
lymphocyt
choriomening
viru
lasv
belong
old
world
famili
high
sequenc
homolog
figur
compar
fusion
core
structur
lcmv
pdb
entri
lasv
found
domain
overlap
well
tloop
helic
region
obviou
differ
figur
tloop
region
lcmv
fusion
core
move
closer
region
helic
region
slope
away
lasv
compar
structur
lcmv
lasv
virus
found
sever
uniqu
featur
arenaviru
protein
figur
region
hiv
form
short
regular
structur
coronavirus
like
merscov
mhv
short
helic
region
longer
helic
region
arenaviru
lasv
lcmv
special
tloop
region
situat
domain
pack
along
linear
region
three
helic
lasv
close
pack
hydrophob
forc
parallel
manner
buri
area
domain
reach
indic
much
stronger
interact
figur
ctermin
interest
two
hydrophil
interact
occur
among
trimer
one
domain
bind
residu
opposit
charg
two
domain
shown
figur
two
residu
highli
conserv
among
differ
arenavirus
suggest
addit
charg
interact
may
play
import
role
enhanc
stabil
end
trimer
tloop
region
domain
well
pack
hydrophob
groov
central
threehel
coil
coil
interfac
figur
tloop
bind
ctermin
end
trimer
linear
domain
deepli
buri
hydrophob
groov
even
helic
domain
mani
hydrophob
residu
long
side
chain
involv
bind
includ
figur
moreov
junction
region
linear
helic
part
sever
strong
hydrogen
bond
salt
bridg
note
hydrogen
bond
hydroxyl
group
interact
one
helix
distanc
carbonyl
oxygen
interact
anoth
helix
distanc
figur
salt
bridg
interact
distanc
interact
distanc
respect
rel
concentr
hydrophil
interact
constitut
anchor
point
middl
domain
stabil
linear
helic
region
also
whole
conform
confirm
secondari
structur
format
fusion
core
ratio
peptid
peptid
mixtur
analyz
circular
dichroism
solut
singl
peptid
show
rel
low
ratio
respect
howev
mix
togeth
form
ratio
larg
increas
figur
consist
crystal
structur
suggest
two
peptid
undergo
significantli
conform
chang
interact
form
fusion
core
elucid
interact
region
lasv
observ
crystal
structur
peptid
peptid
synthes
measur
bind
affin
use
bli
peptid
show
signific
nonspecif
adsorpt
sensor
make
imposs
measur
affin
data
peptid
show
weak
nonspecif
bind
sensor
concentr
use
immobil
molecul
detect
affin
result
show
peptid
could
strongli
bind
peptid
dosedepend
manner
figur
could
hydrophob
hydrophil
interact
peptid
seen
crystal
structur
figur
major
hydrophob
interact
peptid
includ
buri
hydrophob
groov
trimer
core
sever
hydrogen
bond
also
observ
side
chain
oxygen
bind
one
helix
main
chain
oxygen
bind
anoth
helix
figur
bind
interact
howev
despit
potenti
interact
bli
result
show
weak
interact
peptid
possibl
short
peptid
like
may
form
right
conform
bind
target
otherwis
miss
hydrophob
interact
mediat
might
reduc
bind
affin
almost
hydrophil
interact
occur
peptid
peptid
structur
hydrophob
interact
mainli
provid
figur
base
bli
test
strong
interact
found
peptid
therefor
miss
hydrogen
bond
hydrophob
residu
larg
reduc
interact
viral
core
bli
test
peptid
exhibit
interact
peptid
structur
also
show
mani
strong
hydrophob
hydrophil
interact
peptid
ident
residu
provid
hydrophob
interact
includ
figur
also
share
amino
acid
involv
hydrophil
interact
includ
compar
longer
peptid
like
exhibit
optim
conform
fold
suffici
key
residu
interact
trimer
strict
restrict
use
highli
pathogen
virus
facil
abl
get
live
lasv
test
antilasv
activ
thu
test
potenti
inhibitori
activ
peptid
lasv
pseudoviru
entri
target
cell
unexpectedli
none
peptid
exhibit
signific
inhibitori
activ
entri
lasv
pseudoviru
target
cell
concentr
high
figur
result
suggest
may
interact
protein
mediat
attach
lasv
target
cell
first
step
viral
entri
lasv
may
get
cell
cytoplasm
membran
fusion
neutral
ph
condit
second
step
entri
class
envelop
virus
hiv
merscov
qi
et
al
su
et
al
xia
et
al
next
assess
potenti
inhibitori
activ
peptid
lasv
gpc
proteinmedi
fusion
low
ph
condit
peptid
could
complet
inhibit
fusion
peptid
could
inhibit
fusion
respect
peptid
show
inhibitori
activ
figur
analysi
indic
peptid
inhibit
fusion
dosedepend
manner
half
maxim
inhibitori
concentr
valu
respect
figur
peptid
detect
inhibitori
activ
result
suggest
longer
peptid
could
inhibit
fusion
higher
affin
bind
groov
figur
lasv
may
enter
target
cell
micropinocytosi
membran
fusion
low
ph
condit
solv
crystal
structur
postfus
form
domain
lasv
protein
design
sever
peptid
studi
bind
affin
peptid
inhibitori
activ
viral
entri
found
longer
peptid
higher
bind
affin
peptid
shorter
peptid
possibl
owe
rich
hydrophob
hydrophil
interact
figur
moreov
longer
peptid
exhibit
obviou
inhibitori
activ
lasv
g
proteinmedi
fusion
result
suggest
longer
peptid
stronger
affin
domain
also
potent
inhibitori
activ
contrari
shorter
peptid
interact
peptid
thu
show
fusion
inhibitori
activ
fusion
process
protein
lasv
bind
target
receptor
expos
subunit
domain
bind
domain
form
fusion
core
mediat
format
membran
fusion
pore
time
domain
becom
expos
target
bind
block
peptid
therefor
bind
affin
peptid
posit
relat
inhibitori
activ
lasv
gpc
proteinmedi
fusion
low
ph
condit
howev
peptid
show
weak
inhibitori
activ
lasv
pseudoviru
entri
target
cell
confirm
interact
protein
block
interact
receptor
target
cell
first
step
viral
entri
find
also
suggest
lasv
enter
target
cell
use
fusion
pathway
differ
util
class
envelop
virus
hiv
merscov
qi
et
al
su
et
al
xia
et
al
get
host
cell
via
cytoplasm
membran
fusion
neutral
ph
condit
sever
group
shown
lasv
enter
host
cell
via
clathrin
dynaminindepend
endocytosi
membran
fusion
occur
low
ph
vela
et
al
rojek
et
al
opplig
cowork
opplig
et
al
recent
report
lasv
enter
target
cell
macropinocytosi
sinc
result
consist
report
propos
infect
model
lasv
figur
specif
lasv
enter
target
cell
via
endocytosi
includ
macropinocytosi
membran
fusion
process
reveal
fusion
assay
trimer
lasv
bind
receptor
eg
trigger
conform
chang
expos
bind
form
result
fusion
viral
envelop
endosom
membran
condit
peptid
could
bind
target
block
viral
infect
howev
entri
process
live
pseudotyp
lasv
domain
viral
expos
endosom
compart
interact
domain
viral
mediat
membran
fusion
low
ph
condit
make
imposs
peptid
enter
endosom
compart
block
membran
fusion
figur
therefor
peptid
must
modifi
exampl
ad
tat
cell
penetr
sequenc
miller
et
al
hydrocarbon
stapl
motif
wang
et
al
enter
endosom
compart
insid
cell
interact
domain
viral
domain
inhibit
membran
fusion
low
ph
bli
test
peptid
exhibit
differ
bind
affin
peptid
even
though
share
hydrophil
hydrophob
residu
interact
nhr
fusion
core
structur
figur
peptid
sever
addit
residu
nterminu
syln
cterminu
rqgktpl
compar
peptid
although
residu
involv
nhrchr
interact
crystal
structur
may
help
stabil
overal
structur
entir
peptid
thu
compar
peptid
stabl
peptid
higher
affin
bind
peptid
figur
well
higher
inhibitori
activ
fusion
figur
therefor
peptid
modifi
develop
antilasv
drug
candid
dataset
gener
studi
found
protein
data
bank
access
number
crystal
structur
fusion
core
lasv
protein
yz
sj
sy
design
experi
yz
sj
rz
wrote
manuscript
xz
bc
perform
protein
purif
crystal
cw
qw
wx
particip
viral
experi
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
